MedTrace Logo

Drug-eluting-stents for Unprotected Left Main Stem Disease (ISAR-LEFT-MAIN)

NCT00133237 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 607

Last updated 2010-03-15

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy of sirolimus- and paclitaxel-eluting stents for treatment of unprotected left main coronary artery disease.

Conditions

  • Coronary Disease

Interventions

DEVICE

Sirolimus-eluting stent

cypher stent is implanted due to randomization.

DEVICE

Paclitaxel-eluting stent

taxus stent is implanted due to randomization.

Sponsors & Collaborators

  • Technical University of Munich

    collaborator OTHER

  • Deutsches Herzzentrum Muenchen

    lead OTHER

Principal Investigators

  • Albert Schömig, MD · Deutsches Herzzentrum Muenchen

  • Adnan Kastrati, MD · Deutsches Herzzentrum Muenchen

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-07-31
Primary Completion
2008-06-30
Completion
2008-06-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00133237 on ClinicalTrials.gov